Skip to main content
Premium Trial:

Request an Annual Quote

Prime Opportunity for Overhaul?

Over at Nature's News blog, Eugenie Samuel Reich reports on discussions over "a third big push … [in] federal investment in research universities" at a recent meeting of the President's Council of Advisors on Science and Technology in Washington, DC. At that meeting, a National Academies panel that is studying the future of American research universities — the group that authored the 2005 "Rising Above the Gathering Storm" report that called on Congress to double science research — sought feedback as to whether it should recommend an overhaul of research universities in the US. At the meeting, the panel's Charles Holliday expressed that his group "feels universities could be more efficient at translating basic research into marketable products," Reich says, adding that the group is now "looking at ways to do that without infringing on the quality of research environments and academic freedom." Harvard University's Venkatesh Narayanamurti "also called for creative thinking on academic-industry partnership," Reich adds.

In a comment to this post, David Martin says that while the US "did invest heavily in university infrastructure during the 1930s," with the current funding climate "it looks as though Congress won't invest in much of anything during the next decade."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.